Parabilis Helicon peptides pair with Regeneron antibodies in Antibody-Helicon Conjugates targeting 'undruggable' targets, with up to $2.2B in milestones.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.